Amphastar Pharmaceuticals, Inc. (AMPH) Stock buybacks 2016–2025
Amphastar Pharmaceuticals, Inc. (AMPH) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$75.6MFY2025 · since FY2016: $9.9M → $75.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $75.6M | -11.6% |
| FY2024 | $85.5M | +47.0% |
| FY2023 | $58.1M | +45.7% |
| FY2022 | $39.9M | +38.2% |
| FY2021 | $28.9M | +18.2% |
| FY2020 | $24.4M | +9.6% |
| FY2019 | $22.3M | -11.0% |
| FY2018 | $25.0M | -18.5% |
| FY2017 | $30.7M | +210.3% |
| FY2016 | $9.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AMPH financial trends
AMPH RevenueAMPH Net incomeAMPH Net marginAMPH Gross profitAMPH Gross marginAMPH Operating incomeAMPH Operating marginAMPH Operating cash flowAMPH Free cash flowAMPH Capital expendituresAMPH Return on equityAMPH Dividends paidAMPH Total assetsAMPH Total liabilitiesAMPH Shareholders’ equityAMPH overview →